Affitech A/S
Major shareholder notification
Affitech A/S 04.04.2012 17:27 --------------------------------------------------------------------------- Release no. 7/2012 Copenhagen and Oslo, 4th April 2012, 2012-04-04 17:27 CEST (GLOBE NEWSWIRE) -- Affitech has today received a major shareholder notification from Trans Nova Investments Ltd. Here Trans Nova Investments Ltd. in accordance with Section 29 of the Danish Securities Trading Act gives notice that Trans Nova Investments Limited's holding of shares and voting rights in Affitech A/S has, as of 4th April 2012 (the settlement date for Trans Nova s public purchase offer to the shareholders of Affitech) been increased from 195,140,258 voting rights/shares of nominal value DKK 0.50 each (corresponding to 40,01% of Affitech A/S voting rights/share capital) to 347,559,802 voting rights/shares of nominal value DKK 0.50 each (corresponding to 71,26% of Affitech A/S voting rights/share capital). About Affitech Affitech A/S is a publicly traded (NASDAQ OMX Copenhagen) human therapeutic antibody company based in Copenhagen, Denmark with R&D facilities in Oslo, Norway. The company utilizes a range of proprietary antibody technologies for the discovery of fully human antibodies for application in oncology, inflammation and other disease areas. CBAS(TM) (Cell Based Antibody Selection) is Affitech's premier discovery engine for the isolation of lead antibodies to cell surface molecules in situ. Several of the Company's proprietary product candidates were generated by CBAS(TM). Further information is available at www.affitech.com. contact Randi Krogsgaard, Director IR & Communications Tel # +45 2320 1001, e-mail: ir@affitech.com News Source: NASDAQ OMX 04.04.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Affitech A/S Denmark Phone: Fax: E-mail: Internet: ISIN: DK0015966592 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden